pillbase.ru

Avtozma

Active substance: tocilizumab

tocilizumab

Centralised EU authorisationActive

Marketing holder: Celltrion Healthcare Hungary Kft.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 6
  • Актемра®
    раствор для подкожного введения, 162 мг/0.9 мл, 0.9 мл (original in Russian, GRLS)
    ЛП-003186
    Ф. Хоффманн-Ля Рош Лтд.
  • Актемра®
    раствор для подкожного введения, 162 мг, 0.9 мл (original in Russian, GRLS)
    ЛП-№(004451)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Актемра®
    концентрат для приготовления раствора для инфузий, 20 мг/мл, 20 мл (original in Russian, GRLS)
    ЛП-№(005225)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Актемра®
    концентрат для приготовления раствора для инфузий, 20 мг/мл, 20 мл (original in Russian, GRLS)
    ЛСР-003012/09
    Ф. Хоффманн-Ля Рош Лтд.
  • Компларейт®
    концентрат для приготовления раствора для инфузий, 20 мг/мл, 10 мл (original in Russian, GRLS)
    ЛП-№(006657)-(РГ-RU)
    Акционерное общество "ГЕНЕРИУМ" (АО "ГЕНЕРИУМ")
All products in this country (6)
US 22
  • ACTEMRA
    INJECTION, SOLUTION, CONCENTRATE · TOCILIZUMAB 400 mg/20mL
    50242-137
    Genentech, Inc.
  • ACTEMRA
    INJECTION, SOLUTION, CONCENTRATE · TOCILIZUMAB 200 mg/10mL
    50242-136
    Genentech, Inc.
  • ACTEMRA
    INJECTION, SOLUTION, CONCENTRATE · TOCILIZUMAB 80 mg/4mL
    50242-135
    Genentech, Inc.
  • AVTOZMA
    INJECTION, SOLUTION · TOCILIZUMAB 200 mg/10mL
    72606-043
    CELLTRION USA, Inc.
  • AVTOZMA
    INJECTION, SOLUTION · TOCILIZUMAB 400 mg/20mL
    72606-044
    CELLTRION USA, Inc.
All products in this country (22)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2e90-7840-bb17-91291b260e6a,01a120c3-610f-7235-b903-1efb61877d9a,01a120c3-6a2c-71ff-9ce6-de8578e005cd,01a120c3-7e4c-7a8f-a52a-c2c5736f6aec,01a120c3-c922-7571-a3a4-de57100f2827;count=6 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2cdf-7eb5-9033-5b585f91742c,01a1208c-959c-7143-b2bf-7a9efe98a1df,01a1208c-98bb-7cc2-be54-f8b8995c1ed0,01a1208d-3064-789a-a2cb-baa5452e9cea,01a1208d-3067-7bed-9bfe-3e27a0a8d4dd;count=22 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006196
Registration status
Active
ATC code
L04AC07
Sources
  • product · EMA · EMEA/H/C/006196 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006196 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006196 · Verified 2026-10-09